MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1355.35%
Quick Ratio
1331.40%
Cash Ratio
140.65%
Debt to Asset Ratio
7.33%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
24,208
24,772
25,179
25,399
Marketable securities
195,795
233,613
267,168
176,773
Accounts receivable, net
442
343
329
-
Inventory
4,121
3,498
2,936
949
Prepaid expenses and other current assets
8,716
6,141
5,800
3,876
Restricted cash
-
-
0
0
Total current assets
233,282
268,367
301,412
206,997
Property and equipment, net
1,002
1,096
1,189
1,258
Operating lease right-of-use asset
521
619
734
847
Other assets
1,791
2,453
2,541
1,602
Total assets
236,596
272,535
305,876
210,704
Accounts payable
6,648
10,929
4,167
4,323
Accrued liabilities
9,779
14,877
17,020
11,993
Deferred revenue
785
-
-
-
Total current liabilities
17,212
25,806
21,187
16,316
Operating lease liability, net
122
237
350
461
Total liabilities
17,334
26,043
21,537
16,777
Common stock, par value of 0.00001 per share 300,000,000 shares authorized 31,416,892 and 31,344,782 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
1
1
1
1
Additional paid-in capital
520,437
515,570
511,237
384,944
Accumulated deficit
-300,547
-268,629
-227,141
-191,245
Accumulated other comprehensive (loss) income
-629
-450
242
227
Total stockholders equity
219,262
246,492
284,339
193,927
Total liabilities and stockholders equity
236,596
272,535
305,876
210,704
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$195,795K (13.89%↑ Y/Y)Cash and cashequivalents$24,208K (-35.63%↓ Y/Y)Prepaid expenses andother current assets$8,716K (119.60%↑ Y/Y)Inventory$4,121K Accounts receivable, net$442K Total current assets$233,282K (9.21%↑ Y/Y)Other assets$1,791K (11.80%↑ Y/Y)Property and equipment,net$1,002K (-14.29%↓ Y/Y)Operating leaseright-of-use asset$521K (-45.67%↓ Y/Y)Total assets$236,596K (8.86%↑ Y/Y)Total liabilities andstockholders equity$236,596K (8.86%↑ Y/Y)Total stockholdersequity$219,262K (6.25%↑ Y/Y)Total liabilities$17,334K (58.06%↑ Y/Y)Accumulated deficit-$300,547K (-72.19%↓ Y/Y)Accumulated othercomprehensive (loss) income-$629K (-1755.26%↓ Y/Y)Additional paid-in capital$520,437K (36.64%↑ Y/Y)Total currentliabilities$17,212K (65.53%↑ Y/Y)Operating leaseliability, net$122K (-78.56%↓ Y/Y)Common stock, par valueof 0.00001 per...$1K (0.00%↑ Y/Y)Accrued liabilities$9,779K (29.63%↑ Y/Y)Accounts payable$6,648K (132.94%↑ Y/Y)Deferred revenue$785K

LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics, Inc. (LENZ)